当前位置:主页 > 医学论文 > 药学论文 >

瑞舒伐他汀对同型半胱氨酸损伤人脐静脉内皮细胞血管细胞间黏附分子-1表达的影响

发布时间:2018-04-08 18:07

  本文选题:瑞舒伐他汀 切入点:内皮细胞 出处:《广东医学》2015年11期


【摘要】:目的探讨瑞舒伐他汀(Rosu)对同型半胱氨酸(Hcy)损伤人脐静脉内皮细胞(HUVECs)血管细胞间黏附分子-1(VCAM-1)表达的影响。方法原代培养HUVECs,2~3代进行试验,MTT实验设立空白对照组、Hcy(0.2~1.2 mmol/L)组、Rosu(0.5、1.0、2.0和5.0 mmol/L)组,实验组:Rosu 1.0 mmol/L和2.0 mmol/L进行预处理细胞,2 h后加入0.6 mmol/L浓度的Hcy损伤HUVECs,Real time PCR法测定VCAM-1 mRNA表达,Western blot法测定细胞VCAM-1蛋白含量;Rosu 2.0 mmol/L+甲羟戊酸(Mev)100μmol/L预处理2 h后再加入0.6mmol/L浓度的Hcy以了解Mev对VCAM-1蛋白表达的影响。结果 Hcy组VCAM-1蛋白和mRNA表达较空白对照组明显增强(P0.05);Rosu组VCAM-1蛋白和mRNA表达较Hcy组明显减弱(P0.05),且Mev不能阻断Rosu的这种作用。结论 Rosu可通过抑制HUVECs表达VCAM-1产生抗炎作用,且这种作用独立于其调脂作用。
[Abstract]:Objective to investigate the effect of rosuvastatin on the expression of intercellular adhesion molecule-1 (VCAM-1) in human umbilical vein endothelial cells (HUVECs) injured by homocysteine (Hcy).Methods the primary culture of HUVECs2 ~ 2 ~ (2 +) was carried out by MTT assay. The control group was established as the control group, the control group was the control group, the control group was the control group, the control group was the control group, the control group was the control group, the control group was the control group, the control group was the control group, the control group was the control group.The cells of the experimental group were pretreated with 1. 0 mmol/L and 2. 0 mmol/L for 2 h, then the cells were pretreated with 0. 6 mmol/L concentration of Hcy for 2 h. The expression of VCAM-1 mRNA was measured by real time PCR method. Western blot method was used to determine the VCAM-1 protein content of the cells. Rosu 2. 0 mmol/L Mevedol 100 渭 mol/L was pretreated for 2 h, then 0.6mmol/L was added.Degree of Hcy to understand the effect of Mev on the expression of VCAM-1 protein.Results the expression of VCAM-1 protein and mRNA in Hcy group was significantly higher than that in control group. The expression of VCAM-1 protein and mRNA in Hcy group was significantly lower than that in Hcy group, and Mev could not block this effect of Rosu.Conclusion Rosu can produce anti-inflammatory effect by inhibiting HUVECs expression of VCAM-1, and this effect is independent of its lipid regulation.
【作者单位】: 中山大学附属第三医院心内科;中山大学附属第三医院放射科;
【分类号】:R96

【共引文献】

相关期刊论文 前7条

1 曲华清;唐强;姚瑾秋;闫晓琳;王硕;刘坤;王宏宇;;急性冠脉综合征合并糖尿病患者血浆hs-CRP、NT-proBNP与心功能及预后的相关性[J];中国医药导刊;2014年11期

2 曲华清;唐强;姚瑾秋;闫晓临;王智;刘坤;;不同剂量瑞舒伐他汀在急性冠脉综合征合并糖尿病患者的疗效及安全性观察[J];北京医学;2015年04期

3 郝宝顺;余舒杰;刘勇;刘定辉;钱孝贤;;瑞舒伐他汀对同型半胱氨酸损伤的人脐静脉内皮细胞超氧化物歧化酶活性和丙二醛含量的影响[J];中国动脉硬化杂志;2013年09期

4 崔炜;;他汀类药物与肾脏[J];临床荟萃;2014年01期

5 李建华;周U,

本文编号:1722741


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/1722741.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户fa9e4***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com